These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 10220561

  • 1. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A, Löffler-Walz C, Kloor D, Delabar U, Horio Y, Kurachi Y, Quast U.
    Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
    [Abstract] [Full Text] [Related]

  • 2. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
    Hambrock A, Löffler-Walz C, Kurachi Y, Quast U.
    Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
    [Abstract] [Full Text] [Related]

  • 3. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U.
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.
    Manley PW, Löffler-Walz C, Russ U, Hambrock A, Moenius T, Quast U.
    Br J Pharmacol; 2001 May; 133(2):275-85. PubMed ID: 11350864
    [Abstract] [Full Text] [Related]

  • 5. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
    Löffler-Walz C, Hambrock A, Quast U.
    Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
    [Abstract] [Full Text] [Related]

  • 6. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J.
    EMBO J; 1998 Oct 01; 17(19):5529-35. PubMed ID: 9755153
    [Abstract] [Full Text] [Related]

  • 7. Binding of K(ATP) channel modulators in rat cardiac membranes.
    Löffler-Walz C, Quast U.
    Br J Pharmacol; 1998 Apr 01; 123(7):1395-402. PubMed ID: 9579735
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A, Löffler-Walz C, Russ U, Lange U, Quast U.
    Mol Pharmacol; 2001 Jul 01; 60(1):190-9. PubMed ID: 11408614
    [Abstract] [Full Text] [Related]

  • 9. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U, Hambrock A, Artunc F, Löffler-Walz C, Horio Y, Kurachi Y, Quast U.
    Mol Pharmacol; 1999 Nov 01; 56(5):955-61. PubMed ID: 10531400
    [Abstract] [Full Text] [Related]

  • 10. Lipids modulate ligand binding to sulphonylurea receptors.
    Klein A, Lichtenberg J, Stephan D, Quast U.
    Br J Pharmacol; 2005 Aug 01; 145(7):907-15. PubMed ID: 15895108
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
    Stephan D, Stauss E, Lange U, Felsch H, Löffler-Walz C, Hambrock A, Russ U, Quast U.
    Br J Pharmacol; 2005 Apr 01; 144(8):1078-88. PubMed ID: 15711591
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
    Matsuo M, Tanabe K, Kioka N, Amachi T, Ueda K.
    J Biol Chem; 2000 Sep 15; 275(37):28757-63. PubMed ID: 10893240
    [Abstract] [Full Text] [Related]

  • 15. Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.
    Amann T, Schell S, Kühner P, Winkler M, Schwanstecher M, Russ U, Quast U.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun 15; 381(6):507-16. PubMed ID: 20352196
    [Abstract] [Full Text] [Related]

  • 16. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M.
    Mol Pharmacol; 1999 Jun 15; 55(6):1060-6. PubMed ID: 10347249
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.